Depression in Parkinson's disease: Biogenic amines in CSF of "de novo" patients

Journal of Neural Transmission

Volumn 103, Issue 12, 1996, Pages 1441-1445

  Kuhn, W ^a   Muller Th ^a   Gerlach, M ^a,b   Sofie, E ^b   Fuchs, G ^c   Heye, N ^a   Prautsch, R ^a   Przuntek, H ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Parkinson Clinic Wohlfahrt   (Germany)

Author keywords

Biogenic amines; Cerebrospinal fluid; Depression; Parkinson's disease

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; 5 HYDROXYINDOLEACETIC ACID; ANTIPARKINSON AGENT; BIOCHEMICAL MARKER; BIOGENIC AMINE; DOPAMINE; HOMOVANILLIC ACID; NORADRENALIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METABOLISM; MOTOR DYSFUNCTION; PARKINSON DISEASE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM;

AGED; DEPRESSION; DOPAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE; PARKINSON DISEASE; SEROTONIN;

EID: 0030475792     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01271258     Document Type: Article

References (18)

1. Agid Y, Cervera P, Hirsch E, Javoy-Agid F, Lehericy S, Raismann R, Ruberg M (1989) Biochemistry of Parkinson's disease 28 years later: a critical review. Mov Disord 4: 126-144
2. Bartholini G, Da Prada M, Pletscher A (1968) Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydrophenylalanine after inhibition of extracerebral decarboxylase. J Pharm Pharmacol 20: 228-229
3. Brown RG, Jahanshahi M (1995) Depression in Parkinson's disease: a psychosocial viewpoint. Adv Neurol 65: 61-84
4. Brown RG, Mac Carthy B, Gotham AM, Der GJ, Marsden CD (1988) Depression and disability in Parkinson's disease: a follow-up study of 132 cases. Psychol Med 18: 49-55
5. Cummings JL (1992) Depression and Parkinson's disease: a review. Am J Psychiatry 149: 443-444
6. Duvoisin RC (1970) The evaluation of extrapyramidal disease. In: Ajuriaguerra J (ed) Monoamines, noyeaux gris centraux et syndrome de Parkinson. Masson, Paris, pp 153-164
7. Fischer PA, Schneider E, Jacobi P (1982) Depressive Verstimmungen bei Parkinson-Kranken im Langzeitverlauf. In: Psychopathologie des Parkinson-Syndroms. Editiones "Roche", Basel, pp 139-152
8. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62
9. Haltenhof H, Schröter C (1994) Depression beim Parkinson Syndrom. Fortschr Neurol Psychiatr 62: 94-101
10. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17: 427-42
11. Kostic VS, Djuricic BM, Covickovic-Sternic N, Bumbasirevic L, Nikolic M, Mrsulja BB (1987) Depression and Parkinson's disease: possible role of serotonergic mechanisms. J Neurol 234: 94-96
12. Mayeux R, Stern Y, Cote L, Williams JBW (1984) Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 34: 642-646
13. Mayeux R, Stern Y, Williams JBW, Cote L, Frantz A, Dyrenfurth I (1986) Clinical and biochemical features of depression in Parkinson's disease. Am J Psychiatry 143: 756-759
14. Mayeux R, Stern Y, Sano M, Williams JBW, Cote LJ (1988) The relationship of serotonin to depression in Parkinson's disease. Mov Disord 3: 237-244
15. McCance-Katz EF, Marek KL, Price LH (1992) Serotonergic dysfunction in depression associated with Parkinson's disease. Neurology 42: 1813-1814
16. Pacchetti G, Bruggi P, Martignoni E, Godi L, Nappi G (1990) Depression and Parkinson's disease: association of identity? Current hypothesis. New Trends Clin Neuropharmacol IV: 13-26
17. Sofic E (1986) Untersuchung von biogenen Aminen, Metaboliten, Ascorbinsäure und Glutathion mittels HPLC-ECD und deren Verhalten in ausgewählten Lebensmitteln und im Organismus von Tier und Mensch. Dissertation, Technische Universität Wien
18. Wagner J, Vitali P, Palfreyman MG, Zraika M, Hout S (1982) Simultaneous determination of 3,4-dihydrophenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-methoxy-phenylalanine, norepinephrine, 3,4-hydroxyphenylacetic acid, homovanillic acid, serotonin and hydroxyindolacetic acid in rat cerebrospinal fluid and brain by high performance liquid chromatography with electrochemical detection. J Neurochem 38: 1241-54